D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients
- 1 October 1995
- journal article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 152 (10), 1444-1449
- https://doi.org/10.1176/ajp.152.10.1444
Abstract
Central D1, D2, and 5-HT2 receptor occupancy in schizophrenic patients treated with clozapine was determined and related to clozapine serum concentrations. Seventeen patients treated with clozapine (125-600 mg/day) were examined with positron emission tomography (PET) and one to three of the following selective radioligands: [11C]SCH23390 (N = 11), [11C]raclopride (N = 16), and [11C]N-methylspiperone (N = 5). Clozapine concentration in serum was determined by gas chromatography/mass spectrometry. D2 receptor occupancy (20%-67%) was lower than that previously determined in patients treated with classical neuroleptics (70%-90%). D1 receptor occupancy (36%-59%) was higher than that induced by classical neuroleptics (0%-44%). 5-HT2 receptor occupancy was very high (84%-94%), even at low clozapine doses. Despite a 20-fold range in clozapine serum concentration (105-2121 ng/ml) at the time of PET examination, D2 receptor occupancy was low in all patients and was not described by the curvilinear relationship between serum drug concentration and receptor occupancy that has been demonstrated for classical antipsychotics. The results confirm in an extended series of patients that clozapine is atypical with regard to degree of D2 receptor occupancy, a finding that may explain the lack of extrapyramidal side effects. The combination of relatively high D1, low D2, and very high 5-HT2 receptor occupancy values is unique to clozapine. Clozapine serum concentrations have not been unequivocally shown to predict clinical effects. In this study, concentration did not predict degree of occupancy in brain. Thus, careful clinical titration cannot be replaced by monitoring of drug concentrations for optimization of clozapine treatment in individual patients.Keywords
This publication has 16 references indexed in Scilit:
- 5-HT2 and D2 dopamine receptor occupancy in the living human brainPsychopharmacology, 1993
- High 5-HT2 receptor occupancy in clozapine treated patients demonstrated by PETPsychopharmacology, 1993
- Positron Emission Tomographic Analysis of Central D1 and D2 Dopamine Receptor Occupancy in Patients Treated With Classical Neuroleptics and ClozapineArchives of General Psychiatry, 1992
- Mechanisms of action of atypical antipsychotic drugs: Implications for novel therapeutic strategies for schizophreniaSchizophrenia Research, 1991
- Striatal dopamine receptor occupancy during and following withdrawal from neuroleptic treatment: correlative evaluation by positron emission tomography and plasma prolactin levelsPsychopharmacology, 1989
- Clozapine for the Treatment-Resistant SchizophrenicArchives of General Psychiatry, 1988
- Determination of clozapine and its N-demethylated metabolite in plasma by use of gas chromatography-mass spectrometry with single ion detectionPsychopharmacology, 1988
- Serial [18F]N-methylspiroperidol PET studies to measure changes in antipsychotic drug D-2 receptor occupancy in schizophrenic patientsBiological Psychiatry, 1988
- Central D2-Dopamine Receptor Occupancy in Schizophrenic Patients Treated With Antipsychotic DrugsArchives of General Psychiatry, 1988
- Preparation of 11C-labelled SCH 23390 for the in vivo study of dopamine D-1 receptors using positron emission tomographyInternational Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1986